Xiaoteng Lv

Title: Xiaoteng Lv: Innovator in Chimeric Antigen Receptor Technology

Introduction

Xiaoteng Lv is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors (CARs). With a total of 2 patents, his work focuses on innovative solutions for treating various types of cancers.

Latest Patents

One of Xiaoteng Lv's latest patents is titled "BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof." This invention provides a BCMA-targeted CAR, which includes a BCMA-targeted scFv, a hinge region, a transmembrane region, and an intracellular signal structure domain. The patent also details a nucleic acid molecule for coding the CAR and a corresponding expression vector, along with CAR-T cells and their applications. The CAR developed by Xiaoteng targets BCMA-positive cells, making it a potential treatment for BCMA-positive B-cell lymphoma, multiple myeloma, and plasma cell leukemia.

Career Highlights

Xiaoteng Lv is currently associated with Cellular Biomedicine Group HK Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer therapies.

Collaborations

Xiaoteng has collaborated with notable colleagues, including Yutian Wei and Lin Zhu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Xiaoteng Lv's contributions to the field of chimeric antigen receptor technology highlight his role as a leading inventor in biomedical engineering. His innovative patents pave the way for new treatment options for cancer patients.